NCT03190018View on ClinicalTrials.gov

A Feasibility Study of Peritoneal Dialysis With CLS PD, Which Removes Toxins and Maintains a Stable Ultrafiltration by Continuously Regenerating a Recirculating Intraperitoneal Fluid, in Patients With End Stage Renal Disease, ESRD, With PD Therapy.

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 1, 2017

Primary Completion Date

March 13, 2018

Study Completion Date

March 31, 2018

Conditions

Peritoneal Dialysis

Interventions

DEVICE

lCarry Life System Peritoneal Dialysis (CLS PD)

The assigned intervention is with the CLS PD device in patients currently receiving peritoneal dialysis for the duration of one study session. A temporary Pigtail catheter is inserted on the same morning as the study session and removed after the session on the same day.

Trial Locations (1)

413 45

Sahlgrenska University Hospital, Gothenburg

All Listed Sponsors

lead

Triomed AB

INDUSTRY

NCT03190018 - A Feasibility Study of Peritoneal Dialysis With CLS PD, Which Removes Toxins and Maintains a Stable Ultrafiltration by Continuously Regenerating a Recirculating Intraperitoneal Fluid, in Patients With End Stage Renal Disease, ESRD, With PD Therapy. | Biotech Hunter | Biotech Hunter